A CRISPR/CAS9-based strategy targets the personalized chimeric neosequence in fusion-driven cancer genome for precision medicine.

Clin Transl Med

Key Laboratory of Gene Engineering of the Ministry of Education, School of Life sciences, Sun Yat-sen University, Guangzhou, China.

Published: March 2021

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7967915PMC
http://dx.doi.org/10.1002/ctm2.355DOI Listing

Publication Analysis

Top Keywords

crispr/cas9-based strategy
4
strategy targets
4
targets personalized
4
personalized chimeric
4
chimeric neosequence
4
neosequence fusion-driven
4
fusion-driven cancer
4
cancer genome
4
genome precision
4
precision medicine
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!